Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FIRST ADVANTAGE CORP | 16,000 | reported | 18 Nov 2009 | tx 61+113,352.17−186,189.17 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 15,000 | 19.49 USD | |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 20,000 | 26.76 USD | |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 16,114 | — | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 16,000 | — | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 970 | — | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 15,000 | — | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 20,000 | — | |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 20,000 | 24.93 USD | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 16,114 | — | |
| 18 Nov 2009 | GRANT_AWARD | FIRST ADVANTAGE CORP | 76.17 | — | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 76.17 | — | |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 970 | 14.99 USD | |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 16,000 | 321.60 USD | |
| 18 Nov 2009 | OTHER | FIRST ADVANTAGE CORP | 20,000 | — | |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 15,000 | 0.00 USD | deriv |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 16,000 | 0.00 USD | deriv |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 20,000 | 0.00 USD | deriv |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 20,000 | 0.00 USD | deriv |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 16,114 | — | deriv |
| 18 Nov 2009 | EXERCISE | FIRST ADVANTAGE CORP | 970 | 0.00 USD | deriv |
| 10 Nov 2009 | SALE | FIRST ADVANTAGE CORP | 998 | — | |
| 10 Nov 2009 | PURCHASE | FIRST ADVANTAGE CORP | 231 | — | |
| 10 Nov 2009 | PURCHASE | FIRST ADVANTAGE CORP | 3,941 | — | |
| 10 Nov 2009 | SALE | FIRST ADVANTAGE CORP | 5,835 | — | |
| 31 Aug 2009 | GRANT_AWARD | FIRST ADVANTAGE CORP | 4,000 | — | deriv |